Microcytosis Without Anemia: Small Cells, Normal Hemoglobin

·

Share

Microcytosis without anemia means your red blood cells are smaller than normal, with a mean corpuscular volume (MCV) below about 80 femtoliters, while your hemoglobin is still within the normal range. The most common explanations are an inherited thalassemia trait and early iron deficiency, and it is usually found by chance on a routine blood test. It is rarely dangerous in itself, but it is worth identifying the cause, because the answer matters for your iron stores, your future blood results, and sometimes your family planning.

I see this finding regularly in people who feel perfectly well and are puzzled by a single flagged number on their report. This guide explains what the result means, why it happens, which tests sort out the cause, and what, if anything, needs to be done.

What Is Microcytosis Without Anemia?

Microcytosis describes the presence of unusually small red blood cells in the bloodstream. The size is reported on a complete blood count as the mean corpuscular volume (MCV), the average volume of a single red cell. In adults, the normal MCV is roughly 80–100 femtoliters.

Anemia, by contrast, is defined by a low hemoglobin. When the cells are small but hemoglobin and the RBC count hold up, the body is compensating. In thalassemia trait, for example, the marrow often makes more red cells than usual, so the total amount of hemoglobin stays near normal even though each cell carries less.

CBC measurement Typical adult range Pattern in microcytosis without anemia
MCV (cell size) 80–100 fL Below 80 fL
MCH (hemoglobin per cell) 27–33 pg Often low
Hemoglobin About 13.5–17.5 g/dL (men), 12.0–15.5 g/dL (women) Normal
RBC count About 4.5–5.9 million/µL (men), 4.1–5.1 million/µL (women) Normal or high in thalassemia trait; normal or low in iron deficiency
RDW (variation in cell size) About 11.5–14.5% Often normal in thalassemia trait; often raised in iron deficiency

Exact ranges differ between laboratories, so compare your values with the range on your own report.

Causes and Underlying Mechanisms

Red cells become small when the developing cell cannot make enough hemoglobin. Hemoglobin needs two ingredients: heme, which contains iron, and globin protein chains. A shortfall in either can shrink the cell.

Thalassemia trait

Thalassemia trait is the carrier state for alpha or beta thalassemia, inherited conditions that reduce production of globin chains. Carriers usually have a normal or near-normal hemoglobin, a clearly low MCV, and a normal or raised red cell count. It is more common in people with Mediterranean, Middle Eastern, African, South Asian, and Southeast Asian ancestry.

Early iron deficiency

Iron deficiency develops in stages. Iron stores fall first, then red cell production becomes iron-limited, and only later does hemoglobin drop. In the middle stage, cells can already be small while hemoglobin remains normal. Our separate guide to iron deficiency without anemia covers this stage in more detail.

Less common causes

  • Anemia of inflammation in early or mild form, where chronic illness locks iron away from the marrow
  • Hemoglobin variants such as hemoglobin E trait
  • Sideroblastic disorders and lead poisoning, which interfere with heme production

Risk factors

A family history of thalassemia or other hemoglobin disorders is the strongest clue. For iron deficiency, risk factors include heavy menstrual periods, pregnancy, frequent blood donation, vegetarian or low-iron diets, and conditions that reduce iron absorption, such as celiac disease. Unexplained iron loss from the gut should always be looked for in men and in women after menopause.

Signs and Symptoms

Most people with microcytosis without anemia have no symptoms. Because hemoglobin is normal, oxygen delivery is maintained and the typical features of anemia, such as fatigue, pallor, and breathlessness, are usually absent.

When symptoms do occur, they tend to come from the underlying cause rather than the small cells. Iron deficiency, even before anemia, can sometimes cause tiredness, brittle nails, hair shedding, restless legs, or cravings to chew ice. These are reasons to check iron studies rather than a sign that something serious is going on.

How Microcytosis Without Anemia Is Diagnosed

The workup is usually straightforward and done with blood tests alone. It helps distinguish this finding from other hematologic disorders that also produce small cells.

  1. Repeat CBC and review of old results. A low MCV that has been stable for years points toward an inherited trait; a falling MCV suggests developing iron deficiency.
  2. Ferritin and iron studies. Ferritin reflects iron stores. A low ferritin confirms iron deficiency, though ferritin can be falsely normal when inflammation is present.
  3. Blood smear. Target cells and basophilic stippling favor thalassemia trait.
  4. Hemoglobin electrophoresis or HPLC. These tests detect beta thalassemia trait, usually as a raised hemoglobin A2, and variants such as hemoglobin E.
  5. Genetic testing. Alpha thalassemia trait often shows a normal electrophoresis, so DNA testing is needed to confirm it when suspected.

Some clinicians also use the Mentzer index, the MCV divided by the RBC count in millions. A value below 13 favors thalassemia trait and above 13 favors iron deficiency. It is a quick screening clue, not a diagnosis.

One practical point: iron deficiency can lower hemoglobin A2 and mask beta thalassemia trait, so electrophoresis is best interpreted once iron stores are replete.

Treatment and Management

Management depends entirely on the cause.

  • Thalassemia trait: no treatment is needed. Iron supplements do not correct the small cells and should not be taken unless iron deficiency is also proven, because unnecessary iron can build up over time.
  • Iron deficiency: oral iron to rebuild stores, plus a search for the reason it developed, such as heavy periods or gastrointestinal blood loss.
  • Anemia of inflammation: treating the underlying inflammatory condition.
  • Rare causes: directed treatment, such as removing a source of lead exposure.

For carriers of thalassemia trait, the most important step is genetic counseling. If both partners carry a trait, a child can inherit a more serious form of thalassemia, so partner testing before or early in pregnancy is recommended. It also helps to record the diagnosis in your medical notes, so future doctors do not repeatedly investigate or treat small red cells as iron deficiency.

Key Takeaways

  • Microcytosis without anemia means small red cells (MCV below about 80 fL) with a normal hemoglobin.
  • Thalassemia trait and early iron deficiency are the two main causes.
  • Ferritin and hemoglobin electrophoresis usually identify which one applies.
  • Thalassemia trait needs no treatment but has implications for family planning.
  • Iron deficiency needs both replacement and an explanation for why it happened.

If you would like broader background, our guide to hematological disorders for patients and caregivers and the red blood cells guide are good starting points.

Frequently Asked Questions

Is microcytosis without anemia serious?

Usually not. Most cases are due to thalassemia trait, which is a lifelong carrier state rather than a disease, or early iron deficiency, which is easy to treat. The important step is identifying the cause so that any iron loss is investigated and carriers receive appropriate counseling.

Should I take iron if my MCV is low?

Only if blood tests confirm low iron stores. If the small cells are due to thalassemia trait, iron will not change the MCV and may cause iron to accumulate. Check ferritin before starting supplements.

Can microcytosis without anemia turn into anemia?

With untreated iron deficiency, yes: hemoglobin can fall over time as stores run out. With thalassemia trait, hemoglobin usually stays stable, though it may dip mildly during pregnancy or illness.

Do I need to repeat my blood test?

After the cause is found, many people need only occasional checks. If iron deficiency was treated, a repeat CBC and ferritin confirm recovery. Carriers of thalassemia trait generally need no routine monitoring beyond standard care.

Written by
Haematology, Platelet Biology
Contact [email protected] TF_Birkle Website University of Michigan Medical School April 23, 2020 Targeting Undruggable Fusions in AML I joined Jim Morrissey’s lab as a PhD student in the fall of 2016, after receiving my B.Sc. and M.Sc. from Heidelberg University, Germany. My thesis project is focused on structure-function studies of the tissue factor – factor VIIa complex, the physiologic activator…
View Full Profile →
Web Admin Avatar